Diabetic eye disease

Endocrinology and Metabolism Clinics of North America

Volumn 25, Issue 2, 1996, Pages 271-291

  Aiello, L P ^a   Cavallerano, J ^a   Bursell, S E ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC RETINOPATHY; LASER COAGULATION; NIGHT BLINDNESS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; SCOTOMA; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 0030010944     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70325-X     Document Type: Article

References (97)

1. A.P. Adamis J.W. Miller M.T. Bernat Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 118 1994 445 450
2. A.P. Adamis D.T. Shima K.T. Yeo Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells Biochem Biophys Res Common 193 1993 631 638
3. L.M. Aiello J.D. Cavallerano Ocular complications of diabetes mellitus C.R. Kahn G.C. Weir Joslin's Diabetes Mellitus ed 13 1994 Lea and Febiger Philadelphia 771 793
4. L.M. Aiello L.I. Rand J.L. Briones Diabetes retinopathy in Joslin Clinic patients with adults-onset diabetes Ophthalmology 88 1981 619 623
5. L.P. Aiello R.L. Avery P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1994 1480 1487
6. Aiello LP, Northrup JM, Keyt BA, et al: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol, in press
7. Aiello LP, Pierce EA, Foley ED, et al: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA, in press
8. American Academy of Ophthalmology Quality of Care Committee Preferred practice pattern: Diabetic retinopathy 1993 American Academy of Ophthalmology San Francisco
9. American Diabetes Association: 1994 Vital Statistics. Alexandria, VA, ADA
10. N. Ashton B. Ward G. Supell Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia Br J Ophthalmol 38 1954 397 432
11. B. Bertram S. Wolf K. Schulte Retinal blood flow in diabetic children and adolescents Graefe's Arch Clin Exp Ophthalmol 98 1991 996
12. R.F. Bradley S.B. Rees C.A. Fager Pituitary ablation in the treatment of diabetic retinopathy Med Clin North Am 49 1965 1105 1124
13. M. Brownlee A. Cerami H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 1315
14. S.-E. Bursell A.C. Clermont H. Wald Correlation between decreased retinal blood flow and increased diacylglycerol in patients with early diabetes Invest Ophthalmol Vis Sci 35 1994 2088
15. S.-E. Bursell A.C. Clermont B. Oren The in vivo effect of endothelins on retinal circulation in non-diabetic and diabetic rats Invest Ophthalmol Vis Sci 36 1995 596
16. A.C. Clermont C. Takagi M.R. Jirousek A PKC β isoform selective antagonist normalized retinal blood flow in STZ diabetic rats: First report of an oral agent selective for the PKC β isoenzyme Invest Ophthalmol Vis Sci 35 1995 S172
17. D.G. Cogan D. Toussaaint T. Kuwabara Retinal vascular patterns. IV. Diabetic retinopathy Arch Ophthalmol 66 1963 366
18. J.A. Corbett R.G. Tilton K. Chang Aminoguanadine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction Diabetes 44 1992 234
19. P.A. Craven C.M. Davidson F.R. DeRubertis Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids Diabetes 39 1990 667
20. DCCT Research Group The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977
21. DCCT Research Group Are continuing studies on metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med 318 1988 246
22. DCCT Research Group Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial Ophthalmology 102 1995 647 661
23. Diabetic Retinopathy Study Report Number 1: Preliminary report on effects of photocoagulation therapy Am J Ophthalmol 81 1976 1 14
24. Diabetic Retinopathy Study Report Number 2: Photocoagulation of proliferative diabetic retinopathy Ophthalmology 85 1978 82
25. Diabetic Retinopathy Study Report Number 3: Four risk factors for severe visual loss in diabetic retinopathy Arch Ophthalmol 97 1979 658
26. Diabetic Retinopathy Study Report Number 7: A modification of the Airlie House classification of diabetic retinopathy Invest Ophthalmol 21 1981 210 226
27. Diabetic Retinopathy Study Report Number 8: Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings Ophthalmology 88 1981 538 600
28. Diabetic Retinopathy Vitrectomy Study Report Number 2: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: Two-year results of a randomized trial Arch Ophthalmol 103 1985 1644 1652
29. H.F. Dvorak T.M. Sioussat L.F. Brown Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels J Exp Med 174 1991 1275 1278
30. Early Treatment Diabetic Retinopathy Study Report Number 1: Photocoagulation for diabetic macular edema Arch Ophthalmol 103 1985 1796 1806
31. Early Treatment Diabetic Retinopathy Study Report Number 2: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema Ophthalmology 94 1987 761 774
32. Early Treatment Diabetic Retinopathy Study Report Number 5: Detection of diabetic macular edema: Ophthalmoscopy versus photography Ophthalmology 96 1989 746 751
33. Early Treatment Diabetic Retinopathy Study Report Number 9: Early photocoagulation for diabetic retinopathy Ophthalmology 98 1991 766 785
34. Early Treatment Diabetic Retinopathy Study Report Number 10: Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification Ophthalmology 98 1991 786 806
35. Early Treatment Diabetic Retinopathy Study Report Number 11: Classification of diabetic retinopathy from fluorescein angiograms Ophthalmology 98 1991 807 822
36. Early Treatment Diabetic Retinopathy Study Report Number 12: Fundus photographic risk factors for progression of diabetic retinopathy Ophthalmology 98 1991 823 833
37. Early Treatment Diabetic Retinopathy Study Report Number 13: Fluorescein angiographic risk factors for progression of diabetic retinopathy Ophthalmology 98 1991 834 840
38. R.L. Engerman Pathogenesis of diabetic retinopathy Diabetes 38 1989 1203
39. R.L. Engerman T.S. Kern Progression of incipient diabetic retinopathy during good glycemic control Diabetes 36 1987 808
40. R.L. Engerman T.S. Kern Experimental galactosemia produces diabetic-like retinopathy Diabetes 33 1984 97
41. R.L. Engerman T.S. Kern Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs Diabetes 42 1993 820
42. G.T. Feke S.M. Buzney H. Ogasawara Retinal circulatory abnormalities in type I diabetes Invest Ophthalmol Vis Sci 35 1994 2968
43. D.A. Greene S.A. Lattimer A.A.F. Sima Sorbitol, phosphoinositides and sodium-potassium ATP-ase in the pathogenesis of diabetic complications N Engl J Med 316 1987 559
44. J.E. Grunwald C.E. Riva S.H. Sinclair Laser Doppler velocimetry study of retinal circulation in diabetes mellitus Arch Ophthalmol 104 1986 991
45. J.E. Grunwald C.E. Riva J. Baine Total retinal volumetric flow rate in diabetic patients with poor glycemic control Invest Ophthalmol Vis Sci 33 1992 356
46. J.E. Grunwald C.E. Riva D.B. Martin Effect of an insulin-induced decreased in blood glucose on the human diabetic retinal circulation Ophthalmology 94 1987 1614
47. 2-breathing on retinal blood flow in patients with background diabetic retinopathy Curr Eye Res 3 1984 239
48. H.-P. Hammes S. Martin K. Federlin Aminoguanadine treatment inhibits the development of experimental diabetic retinopathy Proc Natl Acad Sci USA 88 1991 1155
49. A. Hanneken E. de Juan Jr G.A. Lutty Altered distribution of basic fibroblast growth factor in diabetic retinopathy Arch Ophthalmol 109 1991 1005 1011
50. T. Inoguchi R. Battan E. Handler Preferential elevation of protein kinase C isoform β II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet transplantation Proc Natl Acad Sci U S A 89 1992 11059
51. J.C. Javitt L.P. Aiello L.J. Bassi Detecting and treating retinopathy in patients with type 1 diabetes mellitus Ophthalmology 98 1991 1565 1574
52. J.C. Javitt L.P. Aiello Y.P. Chiang Preventive eye care in people with diabetes is cost-saving to the federal government Diabetes Care 17 1994 909 917
53. P.F. Kador E.G. Robinson J.H. Kinoshita Pharmacology of aldose reductase inhibitors Ann Rev Pharmacol Toxicol 25 1985 691
54. U. Kikkawa Y. Nishizuka The role of protein kinase C in transmembrane signaling Ann Rev Cell Biol 2 1986 149
55. K.J. Kim B. Li J. Winer Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 362 1993 841 844
56. G.L. King S. Johnson G. Wu Possible growth modulators involved in the pathogenesis of diabetic proliferative retinopathy B. Westermark C. Betsholtz B. Hokfelt Growth Factors in Health and Disease 1990 Excerpta Medica New York 303
57. J.H. Kinoshita Mechanisms initiating cataract formation Invest Ophthalmol Vis Sci 13 1974 713
58. H.A. Klein H.B. Moorehead Statistics on Blindness in the Model Reporting Area, 1969-1970 1973 US Department of Health, Education & Welfare Bethesda, MD (DHEW Publication No. [NIH] 73-427, 1970.)
59. R. Klein B.E.K. Klein Vision disorders in diabetes National Diabetes Data Group: Diabetes in America: Diabetes Data Compiled 1984 1985 U S Department of Health and Human Services Bethesda, MD 1 2 (NIH Publication No. 85-1468)
60. B.E. Klein S.E. Moss R. Klein Effect of pregnancy on progression of diabetic retinopathy Diabetes Care 13 1990 34 40
61. M. Kunisaki S.-E. Bursell F. Umeda Normalization of diacyglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured smooth muscle cells exposed to elevated glucose levels Diabetes 43 1994 1372
62. Kunisaki M, Bursell S-E, Clermont AC, et al: Vitamin E treatment prevents diabetes-induced abnormality in retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol, in press
63. T. Kuwabara D. Cogan Studies of retinal vascular patterns. Part 1. Normal architecture Arch Ophthalmol 64 1960 124
64. R. Luft H. Olivecrona D. Ikkos Hypophysectomy in man: Further experiences in severe diabetes mellitus BMJ 2 1955 752 756
65. R. Luft H. Olivecrona B. Sjogren Hypophysectomy in man Nord Med 47 1952 351
66. D.R. McCance D.G. Dyer J.A. Dunn Maillard reaction products and their relations to complications in insulin-dependent diabetes mellitus J Clin Invest 91 1993 2470
67. R. Meyer-Schwickerath A. Pfeiffer W.F. Blum Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease J Clin Invest 92 1993 2620 2625
68. I.C. Michaelson The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases Trans Ophthalmol Soc UK 68 1948 137 180
69. L. Muthukrishnan E. Warder P.L. McNeil Basic fibroblast growth factor is efficiently released from cytosolic storage site through plasma membrane disruptions of endothelial cells J Cell Physiol 148 1991 1 16
70. National Diabetes Data Group Diabetes in America 1994 National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health
71. National Society to Prevent Blindness, Operational Research Department: Vision Problems in the US: A Statistical Analysis [New York] by the National Society to Prevent Blindness, 1980. Available from the National Society to Prevent Blindness, 500 E. Remington Road, Schaumburg, IL 60173
72. V. Patel S. Rassam E. Kohner Retinal blood flow in diabetic retinopathy BMJ 305 1992 678
73. E.A. Pierce R.L. Avery E.D. Foley Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci U S A 92 1995 905 909
74. J. Pirart Diabetes mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973 Diabetes Care 1 1978 168
75. K.H. Plate G. Breier H.A. Weich Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 1992 845 848
76. R.C. Ramsay F.C. Goetz D.E.R. Sutherland Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus N Engl J Med 318 1988 208
77. L.I. Rand A.S. Krolewski L.M. Aiello Multiple factors in the prediction of risk of diabetic retinopathy N Engl J Med 313 1985 1433
78. C.E. Riva J.E. Grunwald S.H. Sinclair Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow Invest Ophthalmol Vis Sci 24 1983 47
79. W.G. Robinson T.N. Tillis N. Laver Diabetes related histopathologies of the rat retina prevented with an aldose reductase inhibitor Exp Eye Res 50 1990 355
80. E.R. Seaquist F.C. Goetz S. Rich Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy N Engl J Med 320 1989 1161
81. D.R. Senger C.A. Perruzzi J. Feder A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines Cancer Res 46 1986 5629 5632
82. T. Shiba T. Inoguchi J.R. Sportsman Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation Am J Physiol 265 28 1993 E783
83. D. Shweiki A. Itin D. Soffer Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
84. V. Simorre-Pinatel M. Guerrin P. Chollet Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway Invest Ophthalmol Vis Sci 35 1994 3393 3400
85. Sorbinil Retinopathy Trial Research Group A randomized trial of Sorbinil, an aldose reductase inhibitor, in diabetic retinopathy Arch Ophthalmol 108 1990 1234
86. S.P. Sutera K. Chang J. Marvel Concurrent increases in regional hematocrit and blood flow in diabetic rats: Prevention by Sorbinil Am J Physiol 263 1992 H945
87. H. Thieme L.P. Aiello H. Takagi Comparative analysis of vascular endothelial growth factor (VEGF) receptors on retinal and aortic microvascular endothelial cells Diabetes 44 1995 98 103
88. + Kidney Int 41 1992 778
89. W.M. Tilton C. Seaman D. Carriero Regulation of glycolysis in the erythrocyte: Role of lactate/pyruvate and NAD/NADH ratios J Lab Clin Med 118 1991 146
90. M.K. Van den Enden J.R. Nyengaard E. Ostrow Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: Implications for diabetic retinopathy Invest Ophthalmol Vis Sci 36 1995 1675
91. I. Vlodavsky J. Folkman R. Sullina Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix Proc Natl Acad Sci U S A 84 1997 2292 2296
92. S.K. West C.T. Valmadrid Epidemiology of risk factors for age-related cataract Surv Ophthalmol 39 1995 323 334
93. J.R. Williamson T. Kawamura C. Kilo Current concepts of the role of polyol metabolism and related metabolic abnormalities in diabetic complications N. Sakamoto K.G.M.M. Alberti N. Hotta Pathogenesis and Treatment of NIDDM and Its Related Problems 1994 Elsevier Science BV Amsterdam 75 81
94. J.R. Williamson K. Chang M. Frangos Hyperglycemia pseudohypoxia and diabetic complications Diabetes 42 1993 801
95. A.I. Winegrad Banting lecture: Does a common mechanism induce the diverse complications of diabetes? Diabetes 36 1987 396
96. S. Wolf O. Arend H. Toonen Retinal capillary blood flow measurement with a scanning laser ophthalmoscope Ophthalmology 98 1991 996
97. A. Yoshida G.T. Feke J. Moralles-Stoppello Retinal blood flow alteration during progression of diabetic retinopathy Arch Ophthalmol 101 1983 225